A novel B cell line established from Ki-1-positive diffuse large cell lymphoma

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Diffuse large cell lymphoma (DLCL) is a significant hematologic malignancy.
• Characterization of specific cell lines aids in understanding disease biology.
• The Ki-1 antigen's role in DLCL requires further investigation.

Purpose of the Study:

• To establish and characterize a novel cell line from a patient with Ki-1-positive DLCL.
• To determine the lineage and properties of the KIS-1 cell line.
• To provide a resource for studying the Ki-1 antigen in B-cell lymphomas.

Main Methods:

• Phenotypic analysis using 22 monoclonal antibodies.
• Genomic analysis including gene rearrangement studies.
• Immunoglobulin chain production assessment.

Main Results:

• KIS-1 cells expressed Ki-1, B4, HLA-DR, and common leukocyte antigens.
• Cells were negative for T-cell, NK-cell, and myeloid lineage markers.
• Genomic analysis revealed immunoglobulin gene rearrangements (JH, J kappa, C lambda) and lambda chain production, confirming B-cell lineage.

Conclusions:

• The KIS-1 cell line is confirmed to be of B-cell lineage.
• Its properties are consistent with the original tumor cells, validating its origin.
• KIS-1 represents a unique B-cell line from Ki-1-positive DLCL, valuable for Ki-1 antigen research.